Charles Schwab
HHS icon

Charles Schwab’s Harte-Hanks HHS Stock Holding History

Charles Schwab’s Portfolio HHS Stock Details HHS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-1,720
Closed -$28K – 3040
2016
Q2 		$28K Sell
1,720
-13,668
-89% -$241K ﹤0.01% 3088
2016
Q1 		$390K Buy
15,388
+255
+2% +$7.83K ﹤0.01% 2680
2015
Q4 		$491K Buy
15,133
+325
+2% +$12.2K ﹤0.01% 2648
2015
Q3 		$523K Buy
14,808
+855
+6% +$38.6K ﹤0.01% 2605
2015
Q2 		$832K Buy
13,953
+369
+3% +$24.8K ﹤0.01% 2499
2015
Q1 		$1.06M Buy
13,584
+522
+4% +$40.4K ﹤0.01% 2348
2014
Q4 		$1.01M Buy
13,062
+1,400
+12% +$91.5K ﹤0.01% 2349
2014
Q3 		$743K Sell
11,662
-487
-4% -$33.1K ﹤0.01% 2438
2014
Q2 		$874K Sell
12,149
-84
-0.7% -$6.49K ﹤0.01% 2381
2014
Q1 		$1.08M Buy
12,233
+1,832
+18% +$143K ﹤0.01% 2247
2013
Q4 		$814K Sell
10,401
-815
-7% -$66.4K ﹤0.01% 2367
2013
Q3 		$976K Buy
11,216
+534
+5% +$48.9K ﹤0.01% 2222
2013
Q2 		$983K Buy
+10,682
New +$884K ﹤0.01% 2171

Other funds holding HHS

Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
EVC
Eidelman Virant Capital Saint Louis, Missouri $136M AUM 15.11% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

Charles Schwab's HHS Position: Q3 2016 in Review

Charles Schwab sold out of Harte-Hanks (HHS) in Q3 2016, closing a stake of 1,720 shares — an estimated $28K sold.

Charles Schwab first reported a position in HHS in Q2 2013 and held it in 13 quarters. The position peaked at $1.08M in Q1 2014. 102 funds tracked by Wall St. Rank hold HHS as of Q3 2016.

  • Charles Schwab reported no remaining Harte-Hanks position as of Q3 2016 after selling out during the quarter.
  • Charles Schwab sold 1,720 Harte-Hanks shares in Q3 2016, an estimated $28K.
  • Charles Schwab first reported a position in Harte-Hanks in Q2 2013 and held it in 13 quarters.
  • Charles Schwab's Harte-Hanks position peaked at $1.08M in Q1 2014.
  • 102 funds tracked by Wall St. Rank held Harte-Hanks as of Q3 2016.

Based on Charles Schwab's 13F filing for Q3 2016, filed 14 Nov 2016.